BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

441 related articles for article (PubMed ID: 1687045)

  • 21. The natural history of human immunodeficiency virus infection among adults in Mumbai.
    Hira SK; Shroff HJ; Lanjewar DN; Dholkia YN; Bhatia VP; Dupont HL
    Natl Med J India; 2003; 16(3):126-31. PubMed ID: 12929853
    [TBL] [Abstract][Full Text] [Related]  

  • 22. In vitro lymphocyte stimulation in patients with lepromatous and borderline tuberculoid leprosy. The effect of dapsone treatment on the response to Mycobacterium leprae antigens, tuberculin purified protein derivative and non-mycobacterial stimulants.
    Reitan LJ; Closs O; Belehu A
    Int J Lepr Other Mycobact Dis; 1982 Dec; 50(4):455-67. PubMed ID: 6763003
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seroprevalence of HIV infection among leprosy patients in Agra, India: trends and perspective.
    Hussain T; Sinha S; Kulshreshtha KK; Katoch K; Yadav VS; Sengupta U; Katoch VM
    Int J Lepr Other Mycobact Dis; 2005 Jun; 73(2):93-9. PubMed ID: 16830651
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mucosal immune dysfunction in AIDS pathogenesis.
    Paiardini M; Frank I; Pandrea I; Apetrei C; Silvestri G
    AIDS Rev; 2008; 10(1):36-46. PubMed ID: 18385779
    [TBL] [Abstract][Full Text] [Related]  

  • 25. T-lymphocytopaenia, opportunistic infections and pathological findings in Ghanaian AIDS patients and their sexual partners.
    Ayisi NK; Wiredu EK; Sata T; Nyadedzor C; Tsiagbe VK; Newman M; Cofie CN; Taneguchi K
    East Afr Med J; 1997 Dec; 74(12):784-91. PubMed ID: 9557423
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Serum samples from patients with mycobacterial infections cross-react with HIV structural proteins Gp41, p55 and p18.
    Hussain T; Sinha S; Katoch K; Yadav VS; Kulshreshtha KK; Singh I; Sengupta U; Katoch VM
    Lepr Rev; 2007 Jun; 78(2):137-47. PubMed ID: 17824484
    [TBL] [Abstract][Full Text] [Related]  

  • 27. HLA and leprosy in the pre and postgenomic eras.
    Geluk A; Ottenhoff TH
    Hum Immunol; 2006 Jun; 67(6):439-45. PubMed ID: 16728267
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Human immunodeficiency virus and leprosy: an update.
    Lockwood DN; Lambert SM
    Dermatol Clin; 2011 Jan; 29(1):125-8. PubMed ID: 21095536
    [TBL] [Abstract][Full Text] [Related]  

  • 29. World Health Organization clinical case definition for AIDS in Africa: an analysis of evaluations.
    Keou FX; BĂ©lec L; Esunge PM; Cancre N; Gresenguet G
    East Afr Med J; 1992 Oct; 69(10):550-3. PubMed ID: 1335410
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The changing pattern of AIDS-defining illnesses with the introduction of highly active antiretroviral therapy (HAART)in a London clinic.
    Ives NJ; Gazzard BG; Easterbrook PJ
    J Infect; 2001 Feb; 42(2):134-9. PubMed ID: 11531320
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cellular immune response to Mycobacterium leprae infection in human immunodeficiency virus-infected individuals.
    Sampaio EP; Caneshi JR; Nery JA; Duppre NC; Pereira GM; Vieira LM; Moreira AL; Kaplan G; Sarno EN
    Infect Immun; 1995 May; 63(5):1848-54. PubMed ID: 7729894
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Leprosy reversal reaction as immune reconstitution inflammatory syndrome in patients with AIDS.
    Batista MD; Porro AM; Maeda SM; Gomes EE; Yoshioka MC; Enokihara MM; Tomimori J
    Clin Infect Dis; 2008 Mar; 46(6):e56-60. PubMed ID: 18269334
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A follow up of T-cell subsets and of anti-M. leprae antibody titer as measured by the FLA-ABS test in Melanesian leprosy patients under polychemotherapy.
    Garraud O; Ribierre O; Bach MA
    Int J Lepr Other Mycobact Dis; 1986 Mar; 54(1):38-45. PubMed ID: 2940306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunobiology of leprosy.
    Kaplan G; Cohn ZA
    Int Rev Exp Pathol; 1986; 28():45-78. PubMed ID: 3516911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Expression of costimulatory molecules (CD80, CD86, CD28, CD152), accessory molecules (TCR alphabeta, TCR gammadelta) and T cell lineage molecules (CD4+, CD8+) in PBMC of leprosy patients using Mycobacterium leprae antigen (MLCWA) with murabutide and T cell peptide of Trat protein.
    Sridevi K; Neena K; Chitralekha KT; Arif AK; Tomar D; Rao DN
    Int Immunopharmacol; 2004 Jan; 4(1):1-14. PubMed ID: 14975355
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CD4+, CD8+, CD3+ cell counts and CD4+/CD8+ ratio among patients with mycobacterial diseases (leprosy, tuberculosis), HIV infections, and normal healthy adults: a comparative analysis of studies in different regions of India.
    Hussain T; Kulshreshtha KK; Yadav VS; Katoch K
    J Immunoassay Immunochem; 2015; 36(4):420-43. PubMed ID: 25350657
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of HIV infection on the clinical spectrum of leprosy in Maiduguri.
    Moses AE; Adelowo KA; Nwankwo EA
    Niger Postgrad Med J; 2001 Jun; 8(2):74-7. PubMed ID: 11487905
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Long-term culture of multibacillary leprosy macrophages isolated from skin lesions: a new model to study Mycobacterium leprae-human cell interaction.
    Moura DF; Teles RM; Ribeiro-Carvalho MM; Teles RB; Santos IM; Ferreira H; Fulco TO; Nery JA; Sampaio EP; Sarno EN
    Br J Dermatol; 2007 Aug; 157(2):273-83. PubMed ID: 17553031
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Leprosy.
    Meyers WM
    Dermatol Clin; 1992 Jan; 10(1):73-96. PubMed ID: 1730174
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Acute pneumonia and cell-mediated immunity in patients with HIV infection].
    Luzzati R; Cazzadori A; Malena M; Mazzi R; Danzi MC; Ciaffoni S; Concia E; Bassetti D
    Minerva Med; 1993 Mar; 84(3):95-101. PubMed ID: 8492971
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.